Familial combined hyperlipidemia in children: Clinical expression, metabolic defects, and management
- 31 August 1993
- journal article
- review article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 123 (2) , 177-184
- https://doi.org/10.1016/s0022-3476(05)81686-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Use of cholestyramine in the treatment of children with familial combined hyperlipidemiaThe Journal of Pediatrics, 1993
- Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemiaJournal of Internal Medicine, 1991
- Nicotinic Acid for the Treatment of HyperlipoproteinemiaThe Journal of Clinical Pharmacology, 1991
- Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liverJournal of Inherited Metabolic Disease, 1990
- Prevalence and expression of familial combined hyperlipidemia in childhoodThe Journal of Pediatrics, 1990
- Biochemical, clinical, genetic and metabolic studies of hyperapo-β-lipoproteinaemiaJournal of Inherited Metabolic Disease, 1988
- Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early AtherosclerosisNew England Journal of Medicine, 1986
- Familial aggregation and early expression of hyperapobetalipoproteinemiaThe American Journal of Cardiology, 1985
- LONG-TERM FOLLOW-UP OF CHILDREN WITH FAMILIAL HYPERCHOLESTEROLÆMIA TREATED WITH CHOLESTYRAMINEThe Lancet, 1980
- DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1977